Related Experiment Video
Updated: May 5, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
15.6K
BLMPred: Predicting linear B-cell epitopes using pre-trained protein language models and machine learning
Barnali Das1, Dmitrij Frishman1
1Department of Bioinformatics, School of Life Sciences, Technical University of Munich, Freising, Germany.
Computational and Structural Biotechnology Journal
|January 15, 2026
Summary
BLMPred accurately identifies linear B-cell epitopes using protein language models. This computational tool aids in developing diagnostics and vaccines by predicting antibody epitopes from primary protein sequences.
Area of Science:
- Immunology
- Bioinformatics
- Computational Biology
Background:
- B-cell epitopes are key for immune responses, crucial for diagnostics, vaccines, and immunotherapy.
- Experimental epitope identification is costly and slow, necessitating efficient computational methods.
Purpose of the Study:
- To introduce BLMPred, a novel computational tool for predicting linear B-cell epitopes.
- To leverage protein language model embeddings for epitope prediction without 3D structures.
Main Methods:
- BLMPred employs a sequence-based approach using pre-trained protein language model embeddings.
- It functions as a binary classifier to predict epitope presence in peptide sequences.
- The method derives local and global protein structural features from the primary amino acid sequence.
Main Results:
- BLMPred demonstrates superior performance compared to existing tools on independent datasets.
- The tool accurately predicts linear B-cell epitopes based solely on sequence information.
- No reliance on 3D protein structures is required for prediction.
Conclusions:
- BLMPred offers a fast, accurate, and accessible method for B-cell epitope prediction.
- The tool can accelerate vaccine design, antibody development, and diagnostic applications.
- Freely available at https://github.com/bdbarnalidas/BLMPred.git, BLMPred supports further research and development.

